Literature DB >> 8635328

The effects of neuromuscular paralysis on systemic and splanchnic oxygen utilization in mechanically ventilated patients.

P E Marik1, D Kaufman.   

Abstract

OBJECTIVE: To evaluate the effect of neuromuscular paralysis on systemic and splanchnic oxygen utilization in patients in respiratory failure during controlled mechanical ventilation.
SETTING: A university-affiliated teaching hospital. INTERVENTION: Mechanically ventilated patients, who were undergoing hemodynamics monitoring and who had a gastric intramucosal pH (pHi) of less than 7.35, were studied. Prior to paralysis, the patients were sedated with lorazepam and morphine to standard end points, and the cardiac output and oxygenation were optimized. The patients were then paralyzed with doxacurium and the ventilator rate adjusted to keep the PaCO2 at baseline value. The hemodynamic and oxygenation profile and pHi were determined prior to paralysis and repeated 2 to 2.5 h later.
RESULTS: Eight patients were studied; their mean age was 63 +/- 8 years and acute physiology and chronic health evaluation II score was 22 +/- 4. The mean fraction of inspired oxygen, positive end-expiratory pressure, and venous admixture ratio prior to the study was 0.7 +/- 0.14, 11.8 +/- 2.4 cm H2O, and 26 +/- 9%, respectively. Prior to paralysis, the mean set assist controlled ventilation rate was 15 +/- 2 breaths/min and the patient rate was 23 +/- 5 breaths/min. With neuromuscular paralysis, the cardiac index fell from 4.6 +/- 2.2 to 4.3 +/- 2.4 L/min/m2 (p=0.1), the oxygen delivery fell from 537 +/- 129 to 471 +/- 95 mL/min/m2 (p=0.03), and the oxygen consumption and extraction ratio fell from 200 +/ 77 to 149 +/- 35 mL/min/m2 (p=0.03) and 36 +/- 5 to 31 +/- 10, respectively (p=0.2). The pHi increased from 7.21 +/- 0.16 to 7.29 +/- 0.1 (p=0.02).
CONCLUSION: In critically ill patients in respiratory failure, neuromuscular paralysis decreased whole body oxygen consumption and increased pHi. Presumably, by eliminating the work of breathing, there is a redistribution of blood flow from the respiratory muscles to the splanchnic and other nonvital vascular beds.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8635328     DOI: 10.1378/chest.109.4.1038

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  8 in total

1.  Effect of muscle relaxation on the oxygenation of human skeletal muscle: a prospective in-vivo experiment using an isolated forearm technique.

Authors:  Ka Young Rhee; Tae-Yop Kim; In Su Oh; Seoung Joon Lee; Thomas Ledowski
Journal:  Korean J Anesthesiol       Date:  2015-01-28

2.  Respiratory oxygen uptake is associated with survival in a cohort of ventilated trauma and burn patients.

Authors:  Duraid Younan; Chee Paul Lin; Robert Johnson; Robert Clark; Lisa Smith; Jean-Francois Pittet; Mali Mathru; David W Miller
Journal:  Am J Emerg Med       Date:  2018-01-04       Impact factor: 2.469

Review 3.  Adjunctive drug treatment in severe hypoxic respiratory failure.

Authors:  S Elsasser; H Schächinger; W Strobel
Journal:  Drugs       Date:  1999-09       Impact factor: 9.546

4.  The effect of neuromuscular blockade on oxygen consumption in sedated and mechanically ventilated pediatric patients after cardiac surgery.

Authors:  J Lemson; J J Driessen; J G van der Hoeven
Journal:  Intensive Care Med       Date:  2008-09-12       Impact factor: 17.440

5.  Influence of mechanical ventilation on blood lactate in patients with acute respiratory failure.

Authors:  A Gil; F Carrizosa; A Herrero; J Martin; J González; A Jareño; J Rivero
Journal:  Intensive Care Med       Date:  1998-09       Impact factor: 17.440

Review 6.  Advances in Ventilator Management for Patients with Acute Respiratory Distress Syndrome.

Authors:  Michael C Sklar; Laveena Munshi
Journal:  Clin Chest Med       Date:  2022-09       Impact factor: 4.967

Review 7.  Acute respiratory distress syndrome.

Authors:  Nuala J Meyer; Luciano Gattinoni; Carolyn S Calfee
Journal:  Lancet       Date:  2021-07-01       Impact factor: 79.321

Review 8.  Myorelaxants in ARDS patients.

Authors:  Sami Hraiech; Takeshi Yoshida; Djillali Annane; Abhijit Duggal; Vito Fanelli; Arnaud Gacouin; Leo Heunks; Samir Jaber; Peter D Sottile; Laurent Papazian
Journal:  Intensive Care Med       Date:  2020-11-07       Impact factor: 17.440

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.